Systemic Disease Associations in a Cohort of Hispanic Patients with Scleritis.
Hispanics
immune-mediated systemic disease
infectious disease
scleritis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
02 Mar 2023
02 Mar 2023
Historique:
received:
11
01
2023
revised:
13
02
2023
accepted:
01
03
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
(1) Purpose: A patient with scleritis may have an associated systemic disease, which is often autoimmunological and seldom infectious in origin. The data regarding such associations in Hispanic populations are scarce. Therefore, we evaluated the clinical characteristics and systemic-disease associations of a cohort of Hispanic patients with scleritis. (2) Methods: A retrospective review of the medical records (January 1990-July 2021) of two private uveitis practices in Puerto Rico was performed. Clinical characteristics and systemic-disease associations observed either at presentation or diagnosed as a consequence of the initial workup were recorded. (3) Results: A total of 178 eyes of 141 patients diagnosed with scleritis were identified. An associated autoimmune disease was present in 33.3% of the patients (rheumatoid arthritis, 22.7%; Sjögren's syndrome, 3.5%; relapsing polychondritis, 2.8%; sarcoidosis, 1.4%; systemic lupus erythematosus, 1.4%; and systemic vasculitis, 0.7%). An associated infectious disease was present in 5.7% of the patients (2.13%, syphilis; 1.41%, herpes simplex; 1.14%, herpes zoster; and 0.71%, Lyme disease). One patient had all-trans retinoic-acid-associated scleritis. Statistical analysis revealed that patients with nodular anterior scleritis were less likely to have an associated immune-mediated disease (OR: 0.21;
Identifiants
pubmed: 36902755
pii: jcm12051969
doi: 10.3390/jcm12051969
pmc: PMC10004097
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ophthalmology. 1994 Jul;101(7):1281-6; discussion 1287-8
pubmed: 8035992
BMC Ophthalmol. 2021 Jan 6;21(1):14
pubmed: 33407267
Eur J Ophthalmol. 2014 May-Jun;24(3):293-8
pubmed: 24242216
Am J Ophthalmol Case Rep. 2018 Jan 17;9:106-111
pubmed: 29468228
Ann Rheum Dis. 1971 Jul;30(4):343-7
pubmed: 4326763
Drugs. 2007;67(1):75-93
pubmed: 17209665
Am J Ophthalmol. 2000 Oct;130(4):469-76
pubmed: 11024419
Am J Ophthalmol. 2008 Mar;145(3):463-471
pubmed: 18061135
Br J Ophthalmol. 1976 Mar;60(3):163-91
pubmed: 1268179
Ophthalmology. 1995 Apr;102(4):687-92
pubmed: 7724185
Ophthalmology. 1991 Apr;98(4):467-71
pubmed: 2052300
J Pers Med. 2022 Jan 14;12(1):
pubmed: 35055420
Ophthalmology. 2012 Jan;119(1):43-50
pubmed: 21963265
Am J Ophthalmol. 1987 Dec 15;104(6):595-7
pubmed: 3688101
Ophthalmology. 2004 Mar;111(3):501-6
pubmed: 15019326
Ocul Immunol Inflamm. 2004 Jun;12(2):143-8
pubmed: 15512984
Br J Ophthalmol. 2016 Sep;100(9):1290-4
pubmed: 26888976
Ophthalmology. 2004 Jul;111(7):1275-9
pubmed: 15234126
Ophthalmology. 1990 Jul;97(7):892-8
pubmed: 2381703
Br J Ophthalmol. 1976 Mar;60(3):192-226
pubmed: 1268180
Ocul Immunol Inflamm. 2016;24(1):93-5
pubmed: 24833404
J Rheumatol. 2012 Feb;39(2):233-9
pubmed: 22174213